| Literature DB >> 29881767 |
Nahid Khosroshahi1, Aliakbar Rahbarimanesh2, Farhad Asadi Boroujeni1, Zahra Eskandarizadeh1, Mojdeh Habibi Zoham3.
Abstract
BACKGROUND: Benign convulsion with mild gastroenteritis is a new clinical entity that occurs in children who are otherwise healthy.Entities:
Keywords: benign; convulsive seizures; gastroenteritis; infant
Year: 2018 PMID: 29881767 PMCID: PMC5987894 DOI: 10.1177/2329048X18773498
Source DB: PubMed Journal: Child Neurol Open ISSN: 2329-048X
Demographic Features of Patients Presenting With Afebrile Convulsion Associated With Mild Gastroenteritis.
| Study Participants | Number of patients, N (%) |
|---|---|
| Age at presentation | |
| 3-12 months | 8 (33.3%) |
| 12-24 months | 2 (6.7%) |
| 24-36 months | 3 (13.3%) |
| 36-48 months | NA |
| Gender | |
| Male | 11 (46.7%) |
| Female | 14 (53.3%) |
| Seasonal distribution | |
| Spring (March-May) | 13 (52%) |
| Summer (June-August) | 2 (8%) |
| Autumn (September-November) | 4 (16%) |
| Winter (December-February) | 6 (24%) |
Abbreviation: NA, not applicable.
Clinical Features and Neurodiagnostic Findings in Patients With Afebrile Convulsion Associated With Mild Gastroenteritis.
| Study Participants | Number of patients, N (%) |
|---|---|
| Type of seizures | |
| Generalized tonic clonic | 24 (93.3%) |
| Focal clonic | 1 (6.7%) |
| Varying type of seizure | 0 |
| Cluster seizure | 8 (33%) |
| Interval between the GI and neurological symptoms | |
| 3 days | 13 (52%) |
| 3-5 days | 12 (48%) |
| More than 5 days | 0 |
| Family history | |
| Febrile seizure | 1 (4%) |
| Afebrile seizure | 0 |
| EEG findings | |
| Normal EEG findings | 22 (88%) |
| Abnormal EEG findings | |
| Slowing | 2 (8%) |
| Generalized | 1 (4%) |
| Focal | 0 |
| Brain imaging | |
| Normal | 10 (100%) |
| Abnormal | 0 |
Abbreviations: EEG, electroencephalography; GI, gastrointestinal.
Clinical Outcomes of Patients With Afebrile Convulsion Associated With Mild Gastroenteritis.
| Study Participants | Number of patients, N (%) |
|---|---|
| Developmental milestones in follow ups | |
| Normal | 25 (100%) |
| Abnormal | 0 |
| Medication(s) usage at presentation | |
| Benzodiazepine and/or phenobarbital | 22 (88%) |
| Phenytoin and phenobarbital | 5 (20%) |
| Duration of antiepileptic treatment | |
| 1 week | 2 (8%) |
| 1-11 weeks | 22 (88%) |
| 12 week | 1 (4%) |
| Seizure recurrence | |
| Yes | 0 |
| No | 25 (100%) |